Menu
04/01/2005
£2.5m to support cystic fibrosis gene therapy research
Health Minister, Lord Warner, has announced the winning bids for £2.5 million to support further research into gene therapy for cystic fibrosis (CF).
The funding commitment was made in the Genetics White Paper, 'Our Inheritance, Our Future: Realising the potential of genetics in the NHS' and will help to ensure that those with cystic fibrosis benefit as soon as possible from the latest advances in genetic knowledge and technologies.
Cystic fibrosis is the most common inheritable disorder in the UK and affects over 7,500 children and adults. It causes mucus to continually build up in the lungs, which causes breathing difficulties and respiratory infections. There is currently no cure, although regular physiotherapy, antibiotics and enzyme supplements can help slow the progression of the disease. However, the life expectancy for individuals with cystic fibrosis is just 30 years.
Following an open call for proposals, two contracts, one to the Institute of Child Health and the other to the UK Cystic Fibrosis Gene Therapy Consortium, have now been awarded to support further essential gene therapy research in this area. The research teams will work on different but complementary strategies in their proposals and have agreed to work together to maximise the likely benefits.
Commenting on the announcement of the further research, Lord Warner said: "The Genetics White Paper set out our vision that the NHS should take maximum advantage of new genetic knowledge and technologies. Supporting this innovative research will help make sure that cystic fibrosis patients benefit as quickly as possible from gene therapy advances. This work represents a major step in our endeavour to relieve the suffering and ultimately find a cure for this terrible disease".
(KMcA/SP)
The funding commitment was made in the Genetics White Paper, 'Our Inheritance, Our Future: Realising the potential of genetics in the NHS' and will help to ensure that those with cystic fibrosis benefit as soon as possible from the latest advances in genetic knowledge and technologies.
Cystic fibrosis is the most common inheritable disorder in the UK and affects over 7,500 children and adults. It causes mucus to continually build up in the lungs, which causes breathing difficulties and respiratory infections. There is currently no cure, although regular physiotherapy, antibiotics and enzyme supplements can help slow the progression of the disease. However, the life expectancy for individuals with cystic fibrosis is just 30 years.
Following an open call for proposals, two contracts, one to the Institute of Child Health and the other to the UK Cystic Fibrosis Gene Therapy Consortium, have now been awarded to support further essential gene therapy research in this area. The research teams will work on different but complementary strategies in their proposals and have agreed to work together to maximise the likely benefits.
Commenting on the announcement of the further research, Lord Warner said: "The Genetics White Paper set out our vision that the NHS should take maximum advantage of new genetic knowledge and technologies. Supporting this innovative research will help make sure that cystic fibrosis patients benefit as quickly as possible from gene therapy advances. This work represents a major step in our endeavour to relieve the suffering and ultimately find a cure for this terrible disease".
(KMcA/SP)
Related UK National News Stories
Click here for the latest headlines.
10 April 2006
Teenager in court over schoolboy murder
A teenager has appeared in court charged with the murder of 11-year-old schoolboy Joe Geeling. The case of the 14-year-old, who cannot be named for legal reasons, has been sent to the crown court.
Teenager in court over schoolboy murder
A teenager has appeared in court charged with the murder of 11-year-old schoolboy Joe Geeling. The case of the 14-year-old, who cannot be named for legal reasons, has been sent to the crown court.
01 May 2007
Trial begins to find childhood blindness cure
A clinical gene therapy trial has begun on order to test a revolutionary treatment for blindness in children. The trial, which has received £1 million funding from the Department of Health, is the first of its kind and could have a significant impact on future treatments for eye disease.
Trial begins to find childhood blindness cure
A clinical gene therapy trial has begun on order to test a revolutionary treatment for blindness in children. The trial, which has received £1 million funding from the Department of Health, is the first of its kind and could have a significant impact on future treatments for eye disease.
07 December 2004
Health research at forefront of Big Lottery Funding
Health and social inclusion are at the forefront of nine awards totalling over £2 million awarded by the Big Lottery Fund today. Announcing today’s funding, Sir Clive Booth, Chair of the Big Lottery Fund, said research into debilitating diseases to help find better methods of treatment was crucial to supporting those who are most vulnerable.
Health research at forefront of Big Lottery Funding
Health and social inclusion are at the forefront of nine awards totalling over £2 million awarded by the Big Lottery Fund today. Announcing today’s funding, Sir Clive Booth, Chair of the Big Lottery Fund, said research into debilitating diseases to help find better methods of treatment was crucial to supporting those who are most vulnerable.
27 August 2013
MS And Parkinson's Sufferers Told They Are Fit To Work
Almost half of people with some progressive conditions, including Parkinson's, who put in a claim for the sickness benefit Employment and Support Allowance (ESA), are being told they will recover enough to look for work in the future.
MS And Parkinson's Sufferers Told They Are Fit To Work
Almost half of people with some progressive conditions, including Parkinson's, who put in a claim for the sickness benefit Employment and Support Allowance (ESA), are being told they will recover enough to look for work in the future.
09 January 2009
First Breast Cancer Gene-Free Baby Born
The first British baby genetically-selected to be free of the breast cancer gene, has been born. Doctors at University College London said the girl and her mother were doing "very well". The baby grew from an embryo screened to ensure it did not contain the faulty BRCA 1 gene, which passes cancer down generations.
First Breast Cancer Gene-Free Baby Born
The first British baby genetically-selected to be free of the breast cancer gene, has been born. Doctors at University College London said the girl and her mother were doing "very well". The baby grew from an embryo screened to ensure it did not contain the faulty BRCA 1 gene, which passes cancer down generations.
-
Northern Ireland WeatherThis Evening and Tonight:Dry for much of the night. Clear periods at first with mist and fog re-forming, Becoming cloudy later tonight with patchy drizzle towards the North Coast. Minimum temperature 3 °C.
